Profile data is unavailable for this security.
About the company
Abingdon Health plc provides lateral flow contract development and manufacturing (CDMO services) and related contract services to an international customer base. It offers its services to an international customer base across industry sectors, which include clinical, self-testing, animal health, plant health, and environmental testing. Its segments include Product sales, Contract manufacturing, Contract development, and Regulatory. Its regulatory services include technical file build, regulatory filing support, implementation of quality management systems and quality assurance. The Company’s CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its Abingdon Simply Test range of self-tests is an ecommerce platform that offers a range of self-tests to enable consumers to manage their own health and wellbeing.
- Revenue in GBP (TTM)5.34m
- Net income in GBP-2.24m
- Incorporated2008
- Employees82.00
- LocationAbingdon Health PLCYork Biotech Campus, Sand HuttonYORK YO41 1LZUnited KingdomGBR
- Phone+44 19 0440 6050Fax+44 19 0446 2122
- Websitehttps://www.abingdonhealth.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
Bivictrix Therapeutics PLC | 0.00 | -2.33m |
Cambridge Nutritional Sciences PLC | 9.05m | -3.21m |
ImmuPharma PLC | 69.96k | -2.99m |
Kanabo Group PLC | 895.00k | -7.99m |
Proteome Sciences plc | 5.03m | -2.44m |
Chill Brands Group PLC | 146.62k | -3.64m |
Provexis plc | 598.08k | -496.59k |
Abingdon Health PLC | 5.34m | -2.24m |
Shield Therapeutics PLC | 13.09m | -33.29m |
Synairgen plc | 0.00 | -9.99m |
Destiny Pharma PLC | 0.00 | -5.66m |
Genincode PLC | 1.72m | -6.73m |
LungLife AI Inc | 36.22k | -4.26m |
OptiBiotix Health PLC | 689.10k | -13.17m |
Oncimmune Holdings PLC | 1.15m | -6.15m |
Incanthera PLC | 0.00 | -1.48m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
Hargreaves Lansdown Asset Management Ltd.as of 08 Sep 2023 | 10.43m | 8.57% |
Unicorn Asset Management Ltd.as of 30 Apr 2024 | 1.93m | 1.58% |